[Federal Register Volume 79, Number 110 (Monday, June 9, 2014)]
[Notices]
[Page 32961]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-13389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Demonstration Projects on
Health Systems Change to Integrate Tobacco Dependence Treatment into
Clinical Care and Assessment of Related Outcomes, Special Interest
Projects (SIP)14-028; and Applied Research and Development of Tools to
Address Point-of-Sale Tobacco Marketing, SIP14-029, Panel B, initial
review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 9:00 a.m.-6:00 p.m., June 18, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Demonstration Projects on Health Systems Change to
Integrate Tobacco Dependence Treatment into Clinical Care and
Assessment of Related Outcomes, SIP14-028; and Applied Research and
Development of Tools to Address Point-of-Sale Tobacco Marketing,
SIP14-029, Panel B, initial review.''
Contact Person for More Information: M. Chris Langub, Ph.D.,
Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F-
80, Atlanta, Georgia 30341, Telephone: (770) 488-3585, [email protected].
This notice is being published on less than 15 days prior to the
meeting date because no earlier notification of the meeting was
practicable.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-13389 Filed 6-6-14; 8:45 am]
BILLING CODE 4163-18-P